Afuco™ Anti-Human HSPD1 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-HSPD1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The humanized antibodies that specifically bind a HSP65 derived peptide are useed for the treatment of immune-related disorders, specifically, inflammatory disorders such as arthritis, IBD, psoriasis, diabetes and MS.
Supplier Creative Biolabs
Product # AFC-358CL
Pricing Inquiry
Host Humanized
Target HSPD1
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.
Feedback